A U.S. Food and Drug Administration advisory panel on Friday recommended approving the first therapy for peanut allergies, which affect over 1.6 million children in the United States, despite raising concerns about the risk of severe allergic reactions it poses to young patients.
As U.S health officials scramble to identify the root cause of hundreds of severe lung illnesses tied to vaping, one possible culprit identified so far is a line of illicit marijuana vape products sold under the brand names "Dank Vapes" and "Chronic Carts."
(Reuters Health) - Women who exhibit many classic symptoms of post-traumatic stress disorder (PTSD) may be much more likely to develop ovarian cancer than their counterparts who don't, a new study suggests.
U.S. and European drug regulators said on Friday they are reviewing the safety of the widely taken heartburn drug ranitidine, commonly known by the brand name Zantac, after they found traces of a probable cancer-causing impurities in some versions of the medicine.
(Reuters Health) - No one can say if it's the walks or the unconditional love, but there's something about owning a dog that goes hand in hand with better heart health, suggests a study in eastern Europe.
Biogen Inc and Eisai Co Ltd are abandoning two late-stage trials for their Alzheimer's treatment in a widely anticipated move that comes months after the companies scrapped trials of another drug for the memory-robbing disease.
The U.S. Food and Drug Administration said on Friday that some medicines containing ranitidine, including Sanofi SA's Zantac, had traces of a probable cancer-causing impurity called N-nitrosodimethylamine (NDMA) at low levels.
The U.S. Department of Justice examined using fentanyl in lethal injections as it prepared last year to resume executing condemned prisoners, a then untested use of the powerful, addictive opioid that has helped fuel a national crisis of overdose deaths.
Kenya on Friday began adding a malaria vaccine to its routine immunization schedule for babies and toddlers, becoming the third African country to roll out the vaccine for a disease that threatens children across the continent.
Biogen Inc and partner Eisai Co Ltd said on Friday they would abandon two late-stage trials testing experimental Alzheimer's treatment elenbecestat, months after scrapping trials of another drug for the memory-robbing disease.
Novartis's investigational multiple sclerosis drug ofatumumab cut the relapse rate in patients by more than half in trials comparing it to Sanofi's Aubagio as the Swiss drugmaker aims to refresh its portfolio of medicines in neurological diseases.
Indonesia will raise the minimum price of cigarettes by more than a third from January next year, a finance ministry spokesman said on Friday, as part of the government's efforts to reduce smoking rates.
A party in Thailand's ruling coalition has proposed a draft law that would allow Thais to grow a limited amount of cannabis at home, less than a year after the country legalised the drug for medicinal purposes and research.